Publications by authors named "Claudio Scavelli"

Claim this Profile
F
First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry.
Luca Galli, Vincenzo Emanuele Chiuri, Giuseppe Di Lorenzo, Salvatore Pisconti, Sabrina Rossetti, Claudio Scavelli

Tumori· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience.
Eufemia S Lutrino, Laura Orlando, Antonio Febbraro, Marianna Giampaglia, Claudio Zamagni, Claudio Scavelli

Tumori· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies.
Marina Elena Cazzaniga, Claudio Verusio, Mariangela Ciccarese, Alberto Fumagalli, Donata Sartori, Claudio Scavelli

Breast Care (Basel)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
Gaetano Facchini, Sabrina Rossetti, Massimiliano Berretta, Carla Cavaliere, Sarah Scagliarini, Claudio Scavelli

J Transl Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, Alberto Fumagalli, Donata Sartori, Claudio Scavelli

Oncotarget· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, Alberto Fumagalli, Donata Sartori, Claudio Scavelli

Oncotarget· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, Alberto Fumagalli, Donata Sartori, Claudio Scavelli

Oncotarget· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.
Mariangela Ciccarese, Alessandra Fabi, Luca Moscetti, Maria Elena Cazzaniga, Luciana Petrucelli, Claudio Scavelli

Breast Cancer Res Treat· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.
Elena Verzoni, Ugo De Giorgi, Lisa Derosa, Orazio Caffo, Francesco Boccardo, Claudio Scavelli

Oncotarget· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of a third-line treatment with eribulin plus trastuzumab in a young breast cancer patient.
Claudio Scavelli, Federica Gallù

Future Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike?
Nicola Calvani, Franco Morelli, Vincenzo Chiuri, Antonio Gnoni, Claudio Scavelli

Med Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma.
Claudio Scavelli, Giulia Di Pietro, Teresa Cirulli, Mauro Coluccia, Angela Boccarelli

Mol Cancer Ther· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma.
Angelo Vacca, Claudio Scavelli, Guido Serini, Giulia Di Pietro, Teresa Cirulli

Blood· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma.
Angelo Vacca, Claudio Scavelli, Vittorio Montefusco, Giulia Di Pietro, Antonino Neri

J Clin Oncol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic cancer and angiogenesis.
Domenico Ribatti, Claudio Scavelli, Aldo M Roccaro, Enrico Crivellato, Beatrice Nico

Stem Cells Dev· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis.
Claudio Scavelli, Elisabetta Weber, Margherita Aglianò, Teresa Cirulli, Beatrice Nico

J Anat· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial cells in the bone marrow of patients with multiple myeloma.
Angelo Vacca, Roberto Ria, Fabrizio Semeraro, Francesca Merchionne, Mauro Coluccia, Claudio Scavelli

Blood· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chemokines and tumors].
Antonio Pellegrino, Angelo Vacca, Claudio Scavelli, Franco Dammacco

Recenti Prog Med· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis